Related references
Note: Only part of the references are listed.Stem Cell Plasticity and Niche Dynamics in Cancer Progression
Noemi Picco et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2017)
CXCR4 in breast cancer: oncogenic role and therapeutic targeting
Chao Xu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low
Alexander Ring et al.
ONCOTARGET (2015)
Enriched CD44+/CD24- population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)
Fei Ma et al.
CANCER LETTERS (2014)
Immune Escape and Survival Mechanisms in Circulating Tumor Cells of Colorectal Cancer
Gunnar Steinert et al.
CANCER RESEARCH (2014)
Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases
Tomohiro Nogami et al.
BREAST CANCER (2014)
A designed peptide targeting CXCR4 displays anti-acute myelocytic leukemia activity in vitro and in vivo
Xiaojin Li et al.
SCIENTIFIC REPORTS (2014)
Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
Suling Liu et al.
STEM CELL REPORTS (2014)
Understanding and targeting cancer stem cells: therapeutic implications and challenges
Ke Chen et al.
ACTA PHARMACOLOGICA SINICA (2013)
Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients
A. Giordano et al.
ANNALS OF ONCOLOGY (2013)
Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
Christine L. Chaffer et al.
CELL (2013)
Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types
Francisco Ferro de Beca et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis
Yi Dong et al.
PATHOLOGY RESEARCH AND PRACTICE (2013)
The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
Lixin Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Relationship of CD44+CD24-/low breast cancer stem cells and axillary lymph node metastasis
Wei Wei et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
Christina Scheel et al.
CELL (2011)
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
Sara Ricardo et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Cancer Cells Cyclically Lose and Regain Drug-Resistant Highly Tumorigenic Features Characteristic of a Cancer Stem-like Phenotype
Kaijie He et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Tumour evolution inferred by single-cell sequencing
Nicholas Navin et al.
NATURE (2011)
Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer
Hiroko Nogi et al.
ONCOLOGY REPORTS (2011)
Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
Panayiotis A. Theodoropoulos et al.
CANCER LETTERS (2010)
Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content
Salvatore Pece et al.
CELL (2010)
Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
So Yeon Park et al.
CLINICAL CANCER RESEARCH (2010)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67
Vilppu J. Tuominen et al.
BREAST CANCER RESEARCH (2010)
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Mark Shackleton et al.
CELL (2009)
High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
Alysha K. Croker et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Identification of local and circulating cancer stem cells in human liver cancer
Zhen Fan Yang et al.
HEPATOLOGY (2008)
Identification of cells initiating human melanomas
Tobias Schatton et al.
NATURE (2008)
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
H. Korkaya et al.
ONCOGENE (2008)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype
Marija Balic et al.
CLINICAL CANCER RESEARCH (2006)
Mechanisms of disease - Cancer stem cells
Craig T. Jordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells
John P. Chute et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
Therese Sorlie et al.
BMC GENOMICS (2006)
CD44(+)/CD24(-) breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
Carol Sheridan et al.
BREAST CANCER RESEARCH (2006)
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
GV Glinsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
G Dontu et al.
GENES & DEVELOPMENT (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
